共 50 条
- [32] Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (01): : 22 - 31
- [33] Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Prevalence, Clinical Predictors and Outcomes KIDNEY & BLOOD PRESSURE RESEARCH, 2017, 42 (05): : 886 - 893